'김갑성' 기자의 전체기사
-
Thyseed Is Set to Support Southeast Asian Families with Safe…
BEIJING, Aug. 6, 2025 -- Thyseed, an established name in global infant care, recently announced plans to introduce its premium, safety-certified feeding solutions to Southeast Asian households in 2025. With an established presence in the United States, Russia, and mainland China, Thyseed is committed to extending its industry-leading safety standards to new markets. Since its inception, Thyseed has championed a commitment to safeguarding infants from their earliest interactions with feeding products in a move to transform infant feeding safety through profound consumer insights and gro
- 김갑성 기자
- 2025-08-06 13:52
-
Everest Medicines Announces Full Approval of NEFECON® in T…
SHANGHAI, Aug. 6, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON®. NEFECON® is indicated to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for disease progression, irrespective of proteinuria levels. With this label u
- 김갑성 기자
- 2025-08-06 13:09
-
4 in 5 APAC consumers take health supplements but half lac…
Preventive health trend driving need for credible and trusted sources of information HONG KONG, Aug. 6, 2025 -- Herbalife, a premier health and wellness company and community, today released findings from its 2025 Asia Pacific Responsible Supplementation Survey, revealing that while there is widespread use of health supplements in Asia Pacific (APAC), many lack the confidence to make good supplement decisions. Four in five (80%) consumers in the region take health supplements regularly, but only half (50%) expressed confidence in their ability to make responsible supplement cho
- 김갑성 기자
- 2025-08-06 11:00
-
アジア・パシフィック地域の消費者の5人中4人が健康サプリメントを摂取、一方で半数が…
予防的な健康志向の高まりが、信頼できる情報源の必要性を後押し 香港、2025年8月6日 -- 健康とウェルネスのリーディング・カンパニーでありコミュニティでもあるHerbalifeは本日、2025 Asia Pacific Responsible Supplementation Surveyの結果を発表し、アジア・パシフィック地域（APAC）では健康サプリメントが広く使用されている一方で、適切なサプリメントの摂取を決定できる自信がない人が多いことが明らかになりました。この地域の消費者の5人のうち4人（80%）は健康サプリメントを定期的に摂取していますが、責任あるサプリメントを確信を持って選択できていると答えたのは半数（50%）にとどまりました。 2025年5月に実施されたこの調査では、アジア・パシフィック地域の健康サプリメントに対する消費者の態度と行動を調査しました。調査では、「責任あるサプリメントの選択」とは、「健康サプリメント製品を摂取する前に、その製品の成分組成、品質、推奨摂取量、摂取制限、他のサプリメントや医薬品との相互作用の可能性について十分に理解する行為」と定義されています。回答者はオーストラリア、香港、インドネシア、日本、韓国、マレーシア、フィリピン、シンガポール、台湾、タイ、ベトナムの11の市場にまたがる
- 김갑성 기자
- 2025-08-06 11:00
-
From AI to Precision Medicine: Taiwan's Smart Healthcare Inn…
DALLAS, Aug. 6, 2025 -- The Smart Healthcare Pavilion at Taiwan Expo USA 2025 will take place at the Kay Bailey Hutchison Convention Center in Dallas, Texas, from August 14 to 16. Featuring two world-leading hospitals and eight cutting-edge companies, the pavilion highlights Taiwan's exceptional strengths in telemedicine, AI-driven solutions, and precision medicine. Smart Hospitals Leading Global Innovation Two hospitals named among Newsweek's World's Best Smart Hospitals 2025 will unveil groundbreaking healthcare innovations: Taichung Veterans General Hospital
- 김갑성 기자
- 2025-08-06 10:43
-
Bracco Imaging Receives Regulatory Approval in China for So…
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 6, 2025 -- Bracco Imaging, a global leader in diagnostic imaging, today announced that its ultrasound contrast agent SonoVue® has been approved by the China's National Medical Products Administration (NMPA) for use in hysterosalpingo contrast sonography (HyCoSy). HyCoSy is a contrast-enhanced ultrasound (CEUS) procedure that helps identifying potential causes of female infertility related to blockage of the fallopian tubes or
- 김갑성 기자
- 2025-08-06 08:00
-
U.S., Japan, and Taiwan Experts Gather at NUWA Forum -- Over 20…
[ 메디채널 김갑성 기자 ] Is Increased Use of PGT-A Always Better? Experts Call for Evidence-Based Use of Mosaic EmbryosChoosing the Right PGT-A Platform: NUWA Fertility and Global Experts Unite to Advance IVF Success TAIPEI, Aug. 6, 2025 -- Preimplantation Genetic Testing for Aneuploidy (PGT-A), a screening method used during IVF to assess embryo chromosomal health, has gained widespread adoption in reproductive medicine worldwide. Yet the accuracy of various PGT-A platforms and their true clinical value remain points of ongoing debate. To dive deeper into the science behind PGT-A and explore
- 김갑성 기자
- 2025-08-06 08:00
-
WuXi AppTec Named Constituent of the FTSE4Good Index Seri…
SHANGHAI, Aug. 6, 2025 -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced its inclusion in the FTSE4Good Index Series for the third consecutive year. This recognition underscores the Company's ongoing commitment to sustainable development and its efforts to build a healthier, more sustainable world. Created by the global index and data provider FTSE Russell, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating
- 김갑성 기자
- 2025-08-06 08:00
-
Medtronic to announce financial results for its first quarter o…
GALWAY, Ireland, Aug. 6, 2025 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026, which ended on Friday, July 25, 2025, A news release containing summary financial information will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com A video webcast to discuss results will begin at 7:00 a.m. CDT and can be accessed at https://investorrelations.medtronic.com Within
- 김갑성 기자
- 2025-08-06 06:21
-
New revolutionary brain tech platform 'ScreenIT' puts smarter…
SYDNEY, Aug. 6, 2025 -- A revolutionary new brain health assessment platform, ScreenIT, has officially launched, marking a major step forward in how brain function is monitored, assessed, and optimised across sport, healthcare, and research sectors. Developed through a close partnership between Your Brain Health (YBH) and digital innovation studio Miroma Project Factory, ScreenIT unifies over 50 brain health assessment tools into a single, intelligent platform designed to support faster, more informed decision-making around concussion, performance, and long-term brain care. Mir
- 김갑성 기자
- 2025-08-06 06:16
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-24_FRI
- Euroclear builds on strong momentum in Q3 2025 16:30
- Light and Moon Together: CHD Celebrates Mid-Autumn Festival Across Southeast Asia 16:03
- Light and Moon Together: CHD Celebrates Mid-Autumn Festival Across Southeast Asia 16:02
- Light and Moon Together: China Huadian Corporation (CHD) Celebrates Mid-Autumn Festival Across Southeast Asia 15:57
- GAC Supplies Official Fleet and 24/7 Support for the 15th National Games in Hong Kong and Macao 15:51
- NTT DOCOMO BUSINESS and NTT Com Asia Launch "APN InterLink" Service in Hong Kong 15:43
- ASEAN-China (Beijing Municipal Administrative Center) Trade and Investment Promotion Conference in Beijing 15:29
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 24일 18시 00분